drugset / Trial / NCT07584876
A Phase 1 Clinical Study in Healthy Participants
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered BW-41012 in Healthy Participants
Timeline
- Start
- 2026-05-29
- Primary completion
- 2027-10-30
- Completion
- 2028-01-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BW-41012 | Unknown | — | Subcutaneous |
Indications
No indication recorded.